Manage Tardive Dyskinesia with Approved Treatments
Tardive dyskinesia (TD) is a complex movement disorder linked to the use of antipsychotic medications, manifesting as involuntary body movements. Understanding TD’s demographics, importance of early detection, and the introduction of FDA-approved treatments such as valbenazine and deutetrabenazine can offer valuable insights into managing and mitigating this condition’s symptoms effectively. Understanding Tardive Dyskinesia and Its […]
3 minute read